ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,064.20
0.91%
Dow Jones
38,225.66
0.85%
US Dollar vs MXN
16.9829
0.06%
Brent Oil
83.805
0.21%
Bitcoin
59,710.93
1.00%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NYSE
  6. abrdn Life Sciences Investors (HQL)

  7. abrdn Life Sciences Investors (HQL) Noticias

HQL abrdn Life Sciences Investors

13.48
0.20 (1.51%)
02 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
abrdn Life Sciences Investors HQL NYSE Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.20 1.51% 13.48 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
13.41 13.33 13.4901 13.48 13.28
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
29/2/202411:37EDGAR2Form NPORT-P - Monthly Portfolio Investments Report on Form..
07/2/202406:55EDGAR2Form SC 13D/A - General statement of acquisition of..
12/1/202410:41EDGAR2Form SC 13D/A - General statement of acquisition of..
04/1/202413:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202415:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/12/202306:54EDGAR2Form SC 13D - General statement of acquisition of beneficial..
22/12/202313:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
22/12/202313:12EDGAR2Form 3 - Initial statement of beneficial ownership of..
12/12/202309:57EDGAR2Form N-CEN - Annual Report for Registered Investment..
11/12/202315:11EDGAR2Form N-CSR - Certified Shareholder Report
15/11/202314:13EDGAR2Form NPORT-P - Monthly Portfolio Investments Report on Form..
06/11/202314:39EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/11/202314:39EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/11/202314:37EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/11/202314:36EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/11/202314:36EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/11/202314:35EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/11/202314:34EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/11/202314:33EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/11/202314:33EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/11/202314:32EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/11/202314:31EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/11/202314:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/11/202314:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/11/202314:29EDGAR2Form 3 - Initial statement of beneficial ownership of..
27/10/202315:57BWTekla Funds Approve New Investment Advisory Agreements With..
13/10/202317:26BWTekla Funds Implore Shareholders of THQ and THW to Vote..
05/10/202313:05BWTekla Funds Urge Shareholders to Vote Immediately to..
29/9/202309:35BWTekla Life Sciences Investors Paid Distribution
27/9/202308:33EDGAR2Form POS EX - Post-effective amendment adding exhibits to..
25/9/202316:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/9/202317:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202307:51BWTekla Funds Announce Adjournment of Special Meetings and..
12/9/202316:06EDGAR2Form 8-K - Current report
30/8/202313:39BWTekla Funds Announce Second Adjournment of Special Meetings..
28/8/202314:31EDGAR2Form NPORT-P - Monthly Portfolio Investments Report on Form..
25/8/202313:35EDGAR2Form N-CSR/A - Certified Shareholder Report: [Amend]
22/8/202314:35EDGAR2Form N-CSR/A - Certified Shareholder Report: [Amend]
15/8/202308:55BWTekla Life Sciences Investors Declares Distribution
14/8/202314:10BWTekla Funds Announce Adjournment of Special Meetings
04/8/202311:05EDGAR2Form N-PX - Annual Report of proxy voting record of..
30/6/202309:35BWTekla Life Sciences Investors Paid Distribution
20/6/202316:48BWTekla Capital Management LLC Announces Proposed Transaction
15/5/202309:36BWTekla Life Sciences Investors Declares Distribution

Su Consulta Reciente

NYSE
HQL
abrdn Life Sciences Inve...
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados